VulnerabilityModified
CVE-2020-14525
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.
LOW 3.5EPSS 0.47%
Does this matter?
Lower severity and a low EPSS score (0.47%). Track it; it rarely justifies an emergency change on its own.
Description
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.
- CVSS 3.1
- 3.5 LOWCVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
- EPSS
- 0.47% probability · 39th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-83
- Affected
- philips/clinical collaboration platform
- Source
- ics-cert@hq.dhs.gov
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party Advisory, US Government Resource
- https://www.philips.com/a-w/security/security-advisories/product-security-2020.html#2020_archive
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.